260 related articles for article (PubMed ID: 15117744)
41. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha.
Kapanci Y; Desmouliere A; Pache JC; Redard M; Gabbiani G
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2163-9. PubMed ID: 8520791
[TBL] [Abstract][Full Text] [Related]
42. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study.
Khalil N; O'Connor RN; Flanders KC; Unruh H
Am J Respir Cell Mol Biol; 1996 Feb; 14(2):131-8. PubMed ID: 8630262
[TBL] [Abstract][Full Text] [Related]
43. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.
Liu H; Ren JG; Cooper WL; Hawkins CE; Cowan MR; Tong PY
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6605-10. PubMed ID: 15096582
[TBL] [Abstract][Full Text] [Related]
44. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.
Farkas L; Farkas D; Ask K; Möller A; Gauldie J; Margetts P; Inman M; Kolb M
J Clin Invest; 2009 May; 119(5):1298-311. PubMed ID: 19381013
[TBL] [Abstract][Full Text] [Related]
45. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis.
Smith DR; Kunkel SL; Standiford TJ; Rolfe MW; Lynch JP; Arenberg DA; Wilke CA; Burdick MD; Martinez FJ; Hampton JN
Am J Respir Crit Care Med; 1995 Jun; 151(6):1965-73. PubMed ID: 7767546
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis.
Khalil N; Parekh TV; O'Connor R; Antman N; Kepron W; Yehaulaeshet T; Xu YD; Gold LI
Thorax; 2001 Dec; 56(12):907-15. PubMed ID: 11713352
[TBL] [Abstract][Full Text] [Related]
47. Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF.
Yasui N; Mori T; Morito D; Matsushita O; Kourai H; Nagata K; Koide T
Biochemistry; 2003 Mar; 42(11):3160-7. PubMed ID: 12641447
[TBL] [Abstract][Full Text] [Related]
48. Angiogenesis-related factors derived from retinal glial (Müller) cells in hypoxia.
Eichler W; Yafai Y; Wiedemann P; Reichenbach A
Neuroreport; 2004 Jul; 15(10):1633-7. PubMed ID: 15232297
[TBL] [Abstract][Full Text] [Related]
49. Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis.
Calabrese F; Lunardi F; Balestro E; Marulli G; Perissinotto E; Loy M; Nannini N; Valente M; Saetta M; Agostini C; Rea F
Pathology; 2012 Apr; 44(3):192-8. PubMed ID: 22406480
[TBL] [Abstract][Full Text] [Related]
50. [The potential role of cytokines expression in idiopathic pulmonary fibrosis].
Guo Z; Cao B; Zhu Y; Xu W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):33-6. PubMed ID: 11812353
[TBL] [Abstract][Full Text] [Related]
51. Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma.
Głodkowska-Mrówka E; Górska E; Ciurzyński M; Stelmaszczyk-Emmel A; Bienias P; Irzyk K; Siwicka M; Lipińska A; Ciepiela O; Pruszczyk P; Demkow U
Respir Physiol Neurobiol; 2015 Apr; 209():69-75. PubMed ID: 25447676
[TBL] [Abstract][Full Text] [Related]
52. The pathogenesis of idiopathic pulmonary fibrosis.
Coward WR; Saini G; Jenkins G
Ther Adv Respir Dis; 2010 Dec; 4(6):367-88. PubMed ID: 20952439
[TBL] [Abstract][Full Text] [Related]
53. Pigment epithelium-derived factor: a not so sympathetic regulator of insulin resistance?
Bell C
Exerc Sport Sci Rev; 2011 Oct; 39(4):187-90. PubMed ID: 21697716
[TBL] [Abstract][Full Text] [Related]
54. Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?
Tzouvelekis A; Anevlavis S; Bouros D
Respir Res; 2006 May; 7(1):82. PubMed ID: 16725031
[TBL] [Abstract][Full Text] [Related]
55. Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.
Schmitz JC; Protiva P; Gattu AK; Utsumi T; Iwakiri Y; Neto AG; Quinn M; Cornwell ML; Fitchev P; Lugea A; Crawford SE; Chung C
Am J Pathol; 2011 Dec; 179(6):2990-9. PubMed ID: 21964188
[TBL] [Abstract][Full Text] [Related]
56. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.
Kang H; Aryal Ac S; Barnes AM; Martin A; David V; Crawford SE; Marini JC
J Bone Miner Res; 2022 May; 37(5):925-937. PubMed ID: 35258129
[TBL] [Abstract][Full Text] [Related]
57. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis.
Keane MP; Belperio JA; Burdick MD; Lynch JP; Fishbein MC; Strieter RM
Am J Respir Crit Care Med; 2001 Dec; 164(12):2239-42. PubMed ID: 11751193
[TBL] [Abstract][Full Text] [Related]
58. [Pulmonary fibrosis. The fibrogenic factors and therapeutic possibilities].
Lozano J; Hermosa MJ; Sánchez Martín MM; Angel-Moreno A; de Lera JM; de la Vega M; Sánchez Ramos M; Pérez Arellano JL
An Med Interna; 2000 Oct; 17(10):549-54. PubMed ID: 11109653
[No Abstract] [Full Text] [Related]
59. Dual Pigment Epithelium-derived Factor and Hepatocyte Growth Factor Overexpression: A New Therapy for Pulmonary Hypertension.
Qiu F; Jiang B; Lin Y; Li H; Li D; Luo M; Hui H; Miao H; Zhang Y
Am J Respir Cell Mol Biol; 2023 Jul; 69(1):87-98. PubMed ID: 37094101
[TBL] [Abstract][Full Text] [Related]
60. Deficiency in pigment epithelium-derived factor accelerates pulmonary growth and development in a compensatory lung growth model.
Ko VH; Yu LJ; Secor JD; Pan A; Mitchell PD; Kishikawa H; Puder M
FASEB J; 2021 Oct; 35(10):e21850. PubMed ID: 34569654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
